Skip navigation

Pharma's Market

PHARMA WATCH LIST
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Current DateTime: 10:57:31 10 Feb 2012
LinksList Documentid: 23279705
Expiration DateTime: 2/10/2012 11:00:05 AM

SPECIAL REPORT


Current DateTime: 10:57:31 10 Feb 2012
LinksList Documentid: 32984624

MOST SHARED


Current DateTime: 10:57:31 10 Feb 2012
LinksList Documentid: 31330905
Expiration DateTime: 2/10/2012 11:00:45 AM

Current DateTime: 10:57:31 10 Feb 2012
LinksList Documentid: 23452000
Expiration DateTime: 2/10/2012 11:00:40 AM

Current DateTime: 10:57:31 10 Feb 2012
LinksList Documentid: 23452764
Expiration DateTime: 2/10/2012 11:00:24 AM

PHARMA'S MARKET VIDEO

» More

Current DateTime: 10:57:33 10 Feb 2012
LinksList Documentid: 31171988
Expiration DateTime: 2/10/2012 11:00:08 AM

RSS FEED

» Help

Current DateTime: 10:57:33 10 Feb 2012
LinksList Documentid: 31171995

Amgen's Visit From The "Tooth Fairy" (By Way Of Root Canal?)

Published: Wednesday, 7 May 2008 | 11:47 AM ET
Text Size
By: Mike Huckman
Reporter

A visit from the fairy
CNBC.com

There's no money left under the pillow, but Amgen execs and directors have been handed a gift. One of the most outspoken, large, individual investors in the biotech company who's been calling for the Board and CEO to go won't be attending its annual shareholder meeting after all.

I'm outside the Four Seasons Hotel in Westlake Village, CA, where the get-together takes place this afternoon. Reporters will be allowed inside to take notes, but we can't use any recording equipment--i.e. a TV camera.

Anyway, Steve Silverman who has owned AMGN [AMGN  Loading...      ()   ] shares for about two decades and has gotten "very rich" off the investment, was the self-appointed ringleader of a shareholder protest of sorts.

On message boards, in chat rooms and in the media Mr. Silverman was trying to spearhead a campaign to oust Chairman and CEO Kevin Sharer and the Board of Directors. The 70-year-old retired insurance man admits it was a long shot.

related content

He's upset over the stock's decline and what he sees as a series of management missteps. Amgen defends Sharer saying the company has grown "dramatically" on his watch.

(AMGN)
Loading...       (%)

Yesterday afternoon Mr. Silverman sent me an email saying he won't be speaking out at the meeting after all. He explains he has a toothache that requires emergency root canal today.

He added that he spoke to Sharer on the phone yesterday for almost 90 minutes and concluded, "He is interesting but definitely has his views and positions on the company. I still would not vote for him."

An Amgen spokesman confirms the phone call took place, but says that it didn't last quite as long.

Questions?  Comments? 

© 2012 CNBC, Inc. All Rights Reserved


Current DateTime: 10:34:09 10 Feb 2012
LinksList Documentid: 29778428

Current DateTime: 10:34:10 10 Feb 2012
LinksList Documentid: 29779196

Current DateTime: 10:45:45 10 Feb 2012
LinksList Documentid: 29779197

Current DateTime: 10:34:10 10 Feb 2012
LinksList Documentid: 29779199
CNBCCNBC
About CNBC  |  Site Map  |  Video Reprints   |  Advertise  |  Help  |  Contact
Privacy Policy  |     |  Terms of Service  |  Independent Programming Report
  Data is a real-time snapshot  *Data is delayed at least 15 minutes
Global Business and Financial News, Stock Quotes, and Market Data and Analysis

© 2012 CNBC LLC.  All Rights Reserved.
A Division of NBCUniversal
Thomson ReutersThomson Reuters